Risk Benefit Data from the International Duodenal Jejunal Bypass Liner (DJBL) Registry
REJ RYDER1, A ESCALONA2, R LOPEZ-GONZALEZ3, C LAZZARA3, J PUJOL-GEBELLI3, J STEIN4, T BATTELINO5, JP TEARE6, A RUBAN6, M HALUZIK7, L MUNRO8, H FRYDENBERG8, JJ.
REJ RYDER1, A ESCALONA2, R LOPEZ-GONZALEZ3, C LAZZARA3, J PUJOL-GEBELLI3, J STEIN4, T BATTELINO5, JP TEARE6, A RUBAN6, M HALUZIK7, L MUNRO8, H FRYDENBERG8, JJ.
ABCD and UK Kidney Association (UKKA) Diabetic Kidney Disease Clinical Speciality Group have previously undertaken a narrative review and critical appraisal of the available evidence to inform clinical practice guidelines for the pharmacological management of hyperglycemia in adults with T2DM and CKD.
Thursday 11th September 2025, 17:00 - 18:00
Join the Diabetes Technology Network UK (DTN-UK) for a discussion of the current state of hybrid closed loop (HCL) rollout and any issues arising from this.
Together we will explore:
Please note this draft programme is subject to change